Table 1.
Peptide | Sequence | Modification | Application | References |
---|---|---|---|---|
CPPs in cancer detection and treatment | ||||
1. Poly(arginine) | rn = 3–12 | D-Arg | Cell uptake studies and siRNA delivery | Tünnemann et al., 2008; Chung et al., 2017 |
2. cFΦR4Q | Cyclo(FΦRRRRQ)a | Cyclic-poly(Arg) | FITC delivery | Qian et al., 2013 |
3. [WR]5 | Cyclo(WWWWWRRRRR) | Cyclic-poly(Arg) | Au and Se nanoparticles for drug delivery | Shirazi et al., 2014a,b |
4. cTAT | Cyclo(GRKKRRQRRRPQ) | Cyclic-poly(Arg) | GFP delivery | Nischan et al., 2015 |
5. MPG-8 | bAFLGWLGAWGTMGWSPKKKRK-Cya | β-Alab, Cyac | siRNA delivery | Crombez et al., 2009 |
6. Poly(lysine) | D-Lys | CpGg delivery | Hanagata, 2012 | |
7. Poly(lysine) | (Gly–Lys63(NH2)64) | Poly(lysine) dendron | pDNA and siRNA delivery | Al-Jamal et al., 2006; Janiszewska et al., 2016 |
CTPs in cancer detection and treatment | ||||
8. RGD | Cyclo(RGDfV) | Cyclic-RGD D-Phe | Radiotracer and near IR label delivery | Janssen et al., 2002; Ye et al., 2006 |
9. RGD | Cyclo(RGDf[N-Me]V) | Cyclic-RGD D-Phe, N-Me Val | αvβ3 integrin receptor inhibitor | Marinelli et al., 2003 |
10. Pep-42 | CTVALPGGYVRVC-Val-Cit-PABA | Cite, PABAf | Drug delivery | Yoneda et al., 2008 |
11. D-SP5 | prpspkmgvsvs | Retro-inverso D-peptide | pDNA delivery | Li et al., 2015 |
Where Φ is L-2-naphthylalanine.
β-Ala is β-alanine.
Cya is cysteamide.
Variable number of D-Lys units.
Cit is citrulline.
PABA is p-aminobenzyl alcohol.
CpG is cytosine-phosphate-guanosine.